FDA Law Blog

MARCH 6, 2024

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. Claud will be featured at the Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products in New York, NY.

Cosmetics 59

Cosmetics Compliance Generic Drugs Regulation 59

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. These distinctions are important as they determine the regulatory burden required to market a product in Canada. Links to decisions: Le-Vel Brands, LLC v.

Production 52

Production Cosmetics Regulation Branding 52

pharmaphorum

DECEMBER 15, 2022

Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Healthcare Provider (HCP) marketing. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media. Direct-to-Consumer (DTC) marketing.

Clinical Trials 92

Clinical Trials Clinical Trials Life Science Marketing 92

pharmaphorum

OCTOBER 27, 2022

Companies are responsible for all content disseminated via a digital channel when the content is initiated, branded, and/or sponsored by the company or a third party acting on its behalf. Therefore, companies are encouraged to establish a methodology for calculating fair market value rates. What are the key points from the Guidance?

Life Science 93

Life Science Compliance Regulation Cosmetics 93

XTalks

FEBRUARY 16, 2023

In a TV ad called “ Taye Diggs Takes on His Insomnia ,” the actor best known for his role in the Grey’s Anatomy spinoff Private Practice shares his own sleep troubles and how insomnia impacts his days and nights, in a nod to the brands original Seize the Night and Day commercial. The global insomnia market was worth an estimated $5.1

FDA Approval 105

FDA Approval Sales Branding Marketing 105

XTalks

MARCH 13, 2024

This led people to seek it off-label for cosmetic weight loss, a phenomenon many say is partly to blame for the current shortages of both Novo and Lilly’s GLP-1 drugs. Novo’s weight loss version of Ozempic is branded Wegovy (semaglutide). This isn’t the first time the GLP-1 drugs made it to the Oscars.

Medicine 52

Medicine Cosmetics FDA Approval Drugs 52

XTalks

JANUARY 19, 2021

This includes some flavored e-cigarettes imported to the US that do not meet Federal Food, Drug and Cosmetic Act (FD&C Act) requirements, as amended by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act). The warning letters notified the companies to remove their products from the market.

Production 98

Production Cosmetics Marketing Branding 98